A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

MLA

Ruperto, Nicolino, et al. “A Randomized Trial of Parenteral Methotrexate Comparing an Intermediate Dose with a Higher Dose in Children with Juvenile Idiopathic Arthritis Who Failed to Respond to Standard Doses of Methotrexate.” Arthritis and Rheumatism, vol. 50, no. 7, July 2004, pp. 2191–201. EBSCOhost, https://doi.org/10.1002/art.20288.

APA

Ruperto, N., Murray, K. J., Gerloni, V., Wulffraat, N., de Oliveira, S. K. F., Falcini, F., Dolezalova, P., Alessio, M., Burgos-Vargas, R., Corona, F., Vesely, R., Foster, H., Davidson, J., Zulian, F., Asplin, L., Baildam, E., Consuegra, J. G., Ozdogan, H., Saurenmann, R., … Martini, A. (2004). A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis and Rheumatism, 50(7), 2191–2201. https://doi.org/10.1002/art.20288

Chicago

Ruperto, Nicolino, Kevin J Murray, Valeria Gerloni, Nico Wulffraat, Sheila Knupp Feitosa de Oliveira, Fernanda Falcini, Pavla Dolezalova, et al. 2004. “A Randomized Trial of Parenteral Methotrexate Comparing an Intermediate Dose with a Higher Dose in Children with Juvenile Idiopathic Arthritis Who Failed to Respond to Standard Doses of Methotrexate.” Arthritis and Rheumatism 50 (7): 2191–2201. doi:10.1002/art.20288.